Biodexa Pharmaceuticals Names Gary Shangold Chief Medical Officer - Quick Facts

(RTTNews) - Biodexa Pharmaceuticals PLC (BDRX) announced the appointment of Gary Shangold as Chief Medical Officer with immediate effect. Most recently, Shangold was Chief Medical Officer of Enteris BioPharma, a wholly owned subsidiary of SWK Holdings Corporation.

Stephen Stamp, CEO and CFO of Biodexa said: "As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists with Garys knowledge and experience. I have worked with Gary before at Xanodyne where he was instrumental in securing two NDAs."

For More Such Health News, visit rttnews.com.